பயன்பாடுகள் ஏற்கப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CTT Pharmaceuticals Existing Canadian Patent Confirmed to Include Psychedelic Applications ACCESSWIRE Company Advancing Licensing and Partnership Negotiations Patent Applications Accepted in Australia and Jamaica - Grants Anticipated Shortly HAMILTON, ON / ACCESSWIRE / June 15, 2021 / CTT Pharmaceutical Holdings, Inc., (the Company or CTT ) (OTC PINK:CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, announced today that Canadian law firm Gowlings WLC confirmed that CTT s Canadian patent CA2624110 covering Orally Administrable Wafers applies to all forms of Psychedelic applications. Gowlings legal counsel commented as follows: The Canadian patent is quite broad. It is not limited with respect to including any particular pharmaceutical agent and thus… this patent would cover a film including any additional ingredient, including any drug such as a psychedelic drug, cannabinoids, etc.

United statesMarc lakmaakerHoldings incCompany advancing licensingPartnership negotiationsApplications acceptedOrally administrable wafersOrally administrable compositionCam birgeAurora cannabisDissolve stripsஒன்றுபட்டது மாநிலங்களில்ஹோல்டிங்ஸ் இன்க்கூட்டு பேச்சுவார்த்தைகள்பயன்பாடுகள் ஏற்கப்பட்டதுகேம் பிர்ஜ்